RedixFi
RedixFi

SUDARSCHEM · Concall Summary

SUDARSHAN CHEMICAL INDS L

Concall2026-08-20
Tone: Positive

Sudarshan Chemical Industries Limited held its earnings call on August 14, 2026, to discuss its Q1 FY2027 financial results. Management, led by Chairman Rajesh Rathi, highlighted the company's significant growth since merging with Clariant and Heubach, noting a fourfold increase in revenue and EBITDA, alongside a 60% reduction in net debt. The company reported a robust Q1 performance with revenues exceeding Rs. 2600 Crores and a business EBITDA of Rs. 257 Crores, reflecting a year-on-year growth of over 60%. Management acknowledged challenges from geopolitical issues and rising costs but emphasized their focus on customer-centricity and operational efficiency. They set a goal of achieving a turnover of EUR 700 million and an EBITDA of EUR 35 million for the acquired group, while maintaining a cautious approach to guidance due to current market conditions. The call concluded with management expressing confidence in their ongoing transformation and future performance.

Management expressed confidence in the company's growth and operational improvements.

View source filing →

Earlier concalls

  • 2026-08-13Sudarshan Chemical Industries Limited provided an investor presentation regarding its Q1 FY27 results. The presentation
  • 2026-06-04Sudarshan Chemical Industries Limited held a conference call on May 27, 2026, to discuss its Q4 and full-year financial
  • 2026-05-25Sudarshan Chemical Industries Limited provided an investor presentation regarding its Q4 FY26 results. The presentation

See SUDARSCHEM's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.

Sign up free

Back to SUDARSCHEM snapshot